Social Media Ideas for Aacr Global Affairs

From Pixels to Patients: How AACR on Campus Is Transforming Cancer Research in Colombia

By Michelle Guevara-Nieto, PhD, postdoctoral fellow at the Genomic Epidemiology Branch at the International Agency for Research on Cancer (IARC) and member of the AACR Associate Me...

AACR D3: The ‘Global One-stop Conference’ for Drug Discovery and Development

The inaugural AACR Drug Discovery and Development (AACR D3) meeting will convene experts to reshape the future of oncology therapeutics. The post AACR D3: The ‘Global One-stop Conf...

AACR Annual Meeting 2026 Presidential Sessions Explore Cancer Interception and Prevention

At the AACR Annual Meeting 2026, Lillian Siu shared her research into cancer interception and assembled a panel to discuss targeted cancer prevention. The post AACR Annual Meeting...

Uncommon Cancers, Common Goals: Overcoming the Challenges of Rare Cancer Research

The cochairs of the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers—Andrew Futreal, PhD, FAACR, of The University of Texas MD Anderson Cancer Center;...

At the AACR Annual Meeting 2026, Cancer Grand Challenges Teams Explore How Cancer Forms and Evolves

At the AACR Annual Meeting 2026, a session highlighted progress from four Cancer Grand Challenges teams on the interplay of mutations, promoting factors, and tissue-specific epigen...

Bringing Global Cancer Science Closer To Patients In Asia At 2026 ASCO Breakthrough

Leading researchers, clinicians, and healthcare professionals will gather this June at the American Society of Clinical Oncology’s (ASCO) Breakthrough meeting to discuss the opport...

UK3CR joins CCTG and EORTC in welcoming G7 commitment to accelerate global progress against cancer

Published: 24 June 2026 The Canadian Cancer Trials Group (CCTG), the European Organisation for Research and Treatment of Cancer (EORTC), and the UK Collaborative for Cancer Clinic...

AACR Annual Meeting 2026: Bite-sized Research

At the AACR Annual Meeting 2026, we conducted "Bite-sized Research" interviews with attendees for morsels of knowledge about their work, including Brian G. Morreale, PhD, of the Un...

From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research

At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed how monoclonal antibodies transformed lymphoma treatmen...

The Long Road to Receiving Care—Examining Cancer Disparities in Rural Areas 

The AACR Cancer Disparities Progress Report 2026 included an examination of the growing gap in cancer care between rural and urban areas. The report also featured the stories of se...

From the Bench, AACR Annual Meeting 2026: Innovative Tools Uncover New Insights Into Cancer 

The latest edition of our "From the Bench" series examines creative research approaches presented at the AACR Annual Meeting 2026 enabling new insights into cancer. The post From t...

Cancer Researchers Explain How OMB’s Proposed Changes to Federal Grantmaking Will Cause Delays, Reduce Transparency, and...

Cancer researchers—including Elizabeth M. Jaffee, MD, FAACR, of the Sidney Kimmel Cancer Center at Johns Hopkins; Robert H. Vonderheide, MD, DPhil, FAACR, of the Abramson Cancer C...

Chris Baccash: A Brain Cancer Survivor Who Is Cycling to Make a Difference

After surviving brain cancer, former competitive cyclist Chris Baccash dedicated his life to helping others. Baccash now uses his passion for cycling to make an impact, including b...

ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer

At the year’s biggest cancer meeting, a high-stakes clash between two popular drug classes erupted, and scientists made headway against a once-insurmountable foe.

FDA Approvals in Oncology: April-June 2026 

During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment options available for patients with breast cancer, urin...

Why Cities Are the Starting Point for Tackling the Global Cancer Crisis

GENEVA, July 2 (IPS) - Anyone whose life has been touched by cancer knows that care is highly complex. From first symptoms through diagnosis and treatment, patients may need multi...

Editors’ Picks, June 2026: Preventing Colorectal Cancer, Targeting Neural Cross-talk to Stop Glioblastoma Recurrence, an...

The June edition of Editors’ Picks from the AACR journals included studies on targeting neural cross-talk to stop glioblastoma recurrence, identifying patients with multiple myelom...

Highlights of ASCO 2026: how is cancer care evolving? 

Labiotech heard from experts about the major trends and highlights in cancer care at ASCO 2026. The post Highlights of ASCO 2026: how is cancer care evolving?  appeared first on L...

<![CDATA[Abu Dhabi Advances an Integrated Model for Global Life Sciences Innovation ]]>

Launching the “Every Cancer, Every Story” Webinar Series for South Texas

Cancer is a serious health threat in South Texas. To improve cancer education and care for these communities, the Mid Rio Grande Border Area Health Education Center (MRGB AHEC) is...

NYU Langone Health’s Perlmutter Cancer Center Researchers Unveil Latest Discoveries at 2026 ASCO Annual Meeting

At the forefront of oncology research, NYU Langone Health’s Perlmutter Cancer Center, a National Cancer Institute–designated Comprehensive Cancer Center, has unveiled a series of g...

Editors’ Picks, May 2026: Insights Into CAR T Therapy, Neuron-Tumor Crosstalk in Pancreatic Cancer, and More

In May, AACR's journals editors highlighted studies on CD28’s impact on CAR T-cell activity, the relationship between neurons and pancreatic cancer, and more. The post Editors’ Pic...

<![CDATA[What’s Trending in Oncology? A Discussion Following ASCO 2026 with Anne Marie Robertson from EVERSANA]]>

WHO: Urgent Action Needed for the Future of Cancer Care

UNITED NATIONS, July 15 (IPS) - One in five people will be diagnosed with cancer in their lifetime, and when the emotional and physical toll on close family members is factored in...